Board Meeting7 Aug 2026, 02:40 pm
iSERA Lifesciences Declares Un-Audited Standalone Results
AI Summary
iSERA Lifesciences Ltd (formerly Covidh Technologies Limited) announced that its Board of Directors met on August 7, 2026. The board approved the un-audited standalone financial results for the quarter ended June 30, 2026, along with the independent auditor's limited review report. The company operates in the IT/ITES business segment.
Key Highlights
- Board approved un-audited standalone financial results.
- Results are for the quarter ended June 30, 2026.
- Independent auditor's limited review report also approved.
- Company operates in a single IT/ITES business segment.
Price Impact
More from COVIDH